118 related articles for article (PubMed ID: 9292943)
1. Circulating telopeptide type I is a peripheral marker of thyroid hormone action in hyperthyroidism and during levothyroxine suppressive therapy.
Loviselli A; Mastinu R; Rizzolo E; Massa GM; Velluzzi F; Sammartano L; Mela Q; Mariotti S
Thyroid; 1997 Aug; 7(4):561-6. PubMed ID: 9292943
[TBL] [Abstract][Full Text] [Related]
2. High serum circulating telopeptide type I in multinodular goiter.
Loviselli A; Rizzolo E; Mastinu R; Velluzzi F; Secci G; Taberlet A; Mariotti S
Horm Metab Res; 2003 Jun; 35(6):377-81. PubMed ID: 12920662
[TBL] [Abstract][Full Text] [Related]
3. Serum levels of carboxyterminal cross-linked telopeptide of type I collagen (ICTP) in the differential diagnosis of the syndromes of inappropriate secretion of TSH.
Persani L; Preziati D; Matthews CH; Sartorio A; Chatterjee VK; Beck-Peccoz P
Clin Endocrinol (Oxf); 1997 Aug; 47(2):207-14. PubMed ID: 9302396
[TBL] [Abstract][Full Text] [Related]
4. Serum sex hormone-binding globulin and osteocalcin in systemic nonthyroidal illness associated with low thyroid hormone concentrations.
Seppel T; Becker A; Lippert F; Schlaghecke R
J Clin Endocrinol Metab; 1996 Apr; 81(4):1663-5. PubMed ID: 8636386
[TBL] [Abstract][Full Text] [Related]
5. Assessment of sex hormone-binding globulin and osteocalcin in patients undergoing coronary artery bypass graft surgery.
Kunst G; Pfeilschifter J; Kummermehr G; Luntz S; Bauer H; Martin E; Motsch J
J Cardiothorac Vasc Anesth; 2000 Oct; 14(5):546-52. PubMed ID: 11052436
[TBL] [Abstract][Full Text] [Related]
6. Carefully monitored levothyroxine suppressive therapy is not associated with bone loss in premenopausal women.
Marcocci C; Golia F; Bruno-Bossio G; Vignali E; Pinchera A
J Clin Endocrinol Metab; 1994 Apr; 78(4):818-23. PubMed ID: 8157704
[TBL] [Abstract][Full Text] [Related]
7. [Serum levels of the carboxyterminal telopeptide of type I collagen in patients with thyroid disorders].
Conti A; Monzani M; Persani L; Sartorio A
Minerva Endocrinol; 1994 Sep; 19(3):127-31. PubMed ID: 7799894
[TBL] [Abstract][Full Text] [Related]
8. The measurement of the serum sex-hormone binding globulin in various thyroid diseases.
Földes J; Vana S; Bános C; Lakatos P; Tarján G
Acta Med Hung; 1990; 47(1-2):81-90. PubMed ID: 2280997
[TBL] [Abstract][Full Text] [Related]
9. Effects of suppressive doses of levothyroxine treatment on sex-hormone-binding globulin and bone metabolism.
Lecomte P; Lecureuil N; Osorio-Salazar C; Lecureuil M; Valat C
Thyroid; 1995 Feb; 5(1):19-23. PubMed ID: 7787428
[TBL] [Abstract][Full Text] [Related]
10. Sex hormone-binding globulin measurement in patients with inappropriate secretion of thyrotropin (IST): evidence against selective pituitary thyroid hormone resistance in nonneoplastic IST.
Beck-Peccoz P; Roncoroni R; Mariotti S; Medri G; Marcocci C; Brabant G; Forloni F; Pinchera A; Faglia G
J Clin Endocrinol Metab; 1990 Jul; 71(1):19-25. PubMed ID: 2370293
[TBL] [Abstract][Full Text] [Related]
11. Markers of bone turnover in patients with differentiated thyroid cancer with and following withdrawal of thyroxine suppressive therapy.
Toivonen J; Tähtelä R; Laitinen K; Risteli J; Välimäki MJ
Eur J Endocrinol; 1998 Jun; 138(6):667-73. PubMed ID: 9678534
[TBL] [Abstract][Full Text] [Related]
12. Normal serum concentrations of sex hormone binding-globulin in patients with hyperthyroidism due to subacute thyroiditis.
Vierhapper H; Bieglmayer C; Nowotny P; Waldhäusl W
Thyroid; 1998 Dec; 8(12):1107-11. PubMed ID: 9920365
[TBL] [Abstract][Full Text] [Related]
13. Opposite effects of thyroid hormones on binding proteins for steroid hormones (sex hormone-binding globulin and corticosteroid-binding globulin) in humans.
Dumoulin SC; Perret BP; Bennet AP; Caron PJ
Eur J Endocrinol; 1995 May; 132(5):594-8. PubMed ID: 7749500
[TBL] [Abstract][Full Text] [Related]
14. Bone turnover markers in patients with differentiated thyroid carcinoma after levothyroxine withdrawal.
Gao YC; Gu Q; Liu QP; Ge WL; Lu HK
Clin Lab; 2010; 56(3-4):87-93. PubMed ID: 20476639
[TBL] [Abstract][Full Text] [Related]
15. Bone mass, bone turnover, body composition, and calcium homeostasis in former hyperthyroid patients treated by combined medical therapy.
Langdahl BL; Loft AG; Eriksen EF; Mosekilde L; Charles P
Thyroid; 1996 Jun; 6(3):161-8. PubMed ID: 8837321
[TBL] [Abstract][Full Text] [Related]
16. Markers of bone turnover in hyperthyroidism and the effects of treatment.
Garnero P; Vassy V; Bertholin A; Riou JP; Delmas PD
J Clin Endocrinol Metab; 1994 Apr; 78(4):955-9. PubMed ID: 8157727
[TBL] [Abstract][Full Text] [Related]
17. Serum sex hormone-binding globulin in amiodarone-treated patients. A marker for tissue thyrotoxicosis.
Bambini G; Aghini-Lombardi F; Rosner W; Khan MS; Martino E; Pinchera A; Braverman LE; Safran M
Arch Intern Med; 1987 Oct; 147(10):1781-5. PubMed ID: 3662707
[TBL] [Abstract][Full Text] [Related]
18. Sex hormone-binding globulin, estradiol, and bone turnover markers in male osteoporosis.
Lormeau C; Soudan B; d'Herbomez M; Pigny P; Duquesnoy B; Cortet B
Bone; 2004 Jun; 34(6):933-9. PubMed ID: 15193539
[TBL] [Abstract][Full Text] [Related]
19. Bone mass, bone turnover, calcium homeostasis, and body composition in surgically and radioiodine-treated former hyperthyroid patients.
Langdahl BL; Loft AG; Eriksen EF; Mosekilde L; Charles P
Thyroid; 1996 Jun; 6(3):169-75. PubMed ID: 8837322
[TBL] [Abstract][Full Text] [Related]
20. The significance of carboxy-terminal telopeptide of type I collagen (ICTP) and osteocalcin (OC) in assessment of bone disease in patients with multiple myeloma.
Kuliszkiewicz-Janus M; Małecki R; Zółtaszek A; Zastawny M
Leuk Lymphoma; 2005 Dec; 46(12):1749-53. PubMed ID: 16263577
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
